Choukri Mekkaoui Selected Research

Choukri Mekkaoui Research Topics

4	Thrombosis (Thrombus) 01/2022 - 01/2002
3	Neointima 01/2008 - 11/2002
2	Stroke (Strokes) 10/2019 - 04/2006
2	Ischemia 04/2014 - 05/2013
2	Pulmonary Embolism 01/2011 - 08/2007
2	Arterial Occlusive Diseases (Arterial Occlusive Disease) 02/2004 - 01/2003
1	Reperfusion Injury 01/2022
1	Starvation 01/2022
1	Isolated Systolic Hypertension 10/2019
1	Cicatrix (Scar) 01/2018
1	Acute Coronary Syndrome 05/2013
1	Necrosis 11/2011
1	Infarction (Infarctions) 11/2011
1	Myocardial Infarction 03/2011
1	Pathologic Constriction (Stenosis) 10/2009
1	Body Weight (Weight, Body) 12/2002

2	GadoliniumIBA 01/2018 - 11/2011
2	DNA (Deoxyribonucleic Acid)IBA 11/2011 - 12/2002
1	FibrinIBA 01/2022
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2022
1	MethemoglobinIBA 01/2022
1	Chlorthalidone (Chlortalidone)FDA LinkGeneric 10/2019
1	Antihypertensive Agents (Antihypertensives)IBA 10/2019
1	Contrast MediaIBA 01/2018
1	Fluorescent Dyes (Fluorescent Probes)IBA 05/2013
1	CathepsinsIBA 05/2013
1	Sirolimus (Rapamycin)FDA Link 05/2013
1	Gadolinium DTPA (Magnevist)FDA Link 11/2011
1	IsotopesIBA 03/2011
1	Adenosine (Adenocard)FDA LinkGeneric 01/2011
1	regadenoson FDA Link 10/2009
1	Vasodilator Agents (Vasodilators)IBA 10/2009
1	MetalsIBA 01/2008
1	SolutionsIBA 01/2008
1	Simendan (Levosimendan)IBA 08/2007
1	Liposomes (Liposome)IBA 07/2006
1	Peptides (Polypeptides)IBA 07/2006
1	Sevoflurane (Ultane)FDA LinkGeneric 04/2006
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2003
1	CecropinsIBA 11/2002
1	GalactosidasesIBA 11/2002

4	Stents 01/2008 - 01/2002
1	Drug Therapy (Chemotherapy) 01/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2014
1	Therapeutics 05/2013
1	Drug-Eluting Stents 01/2008
1	Aftercare (After-Treatment) 01/2008